Esta página aún no está traducida al español y se muestra en inglés. Estamos trabajando en su traducción.

What the literature supports for each formulation class

A hair and scalp protocol draws on formulation classes with very different evidence behind them, from an FDA-approved oral label to follicle culture and small early trials (Fig. 1). These references take each class on its own terms: what the studies were, what they reported, and what the regulators have said, with the study design labeled beside every citation.

Written for licensed practitioners and practice operators. Two product regimes appear here and never mix: exosome material is supplied for topical aesthetic use, and compounded scalp formulations are 503A prescription products. Neither is FDA-approved for hair loss.

Schematic of three hair follicles showing the anagen growth phase, the catagen regression phase and the telogen resting phase, with an arrow returning to anagen
Fig. 1 | The hair follicle cycle. Anagen (growth), catagen (regression) and telogen (rest) before a new cycle begins.Imagen: ExaVeyra Sciences, adaptada de fuentes publicadascrédito

References

4 of 9 published. The remainder are in review and will appear as they are completed.

The Hair Follicle Cycle and the Levers a Protocol Acts On

The cycle, the dermal papilla, and the four levers.

In review

Finasteride: Mechanism, Approved Label, and Topical Literature

The oral label, the topical literature, and the FDA alert.

Minoxidil, Minoxidil Sulfate, and Follicular Sulfotransferase

The prodrug, the enzyme, and the combinations.

GHK-Cu in Follicle and Dermal Papilla Research

Follicle culture, animal models, and the regulatory position.

Extracellular Vesicles and Dermal Papilla Signaling

The human evidence to date, the registry, and the FDA communications.

Ketoconazole and Azelaic Acid in Scalp Research

The shampoo studies and the in vitro work.

In review

Vitamin D, Biotin, Thyroid and Sex Steroids in Hair Shedding

Deficiency states, endocrine context, and the biotin assay notice.

In review

Microneedling, PRP and Topical Anesthesia in Scalp Protocols

The microneedling literature and the anesthetic formulations.

In review

FDA Communications Relevant to Hair Products

The finasteride alert, the exosome notification, and the biotin notice.

In review

Créditos de imágenes

  1. Fig. 1ExaVeyra Sciences, figura original. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341(7):491-497. DOI article ↩

This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. Leer el aviso completo